1. Home
  2. GABC vs BCRX Comparison

GABC vs BCRX Comparison

Compare GABC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo German American Bancorp Inc.

GABC

German American Bancorp Inc.

HOLD

Current Price

$51.14

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$7.89

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GABC
BCRX
Founded
1910
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
GABC
BCRX
Price
$51.14
$7.89
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
★ $56.20
$20.55
AVG Volume (30 Days)
118.6K
★ 4.7M
Earning Date
11-06-2026
11-04-2026
Dividend Yield
★ 2.44%
N/A
EPS Growth
8.13
★ 381.40
EPS
★ 1.90
N/A
Revenue
★ $487,401,000.00
$25,186,000.00
Revenue This Year
$10.48
N/A
Revenue Next Year
$4.47
$3.71
P/E Ratio
$26.81
★ N/A
Revenue Growth
★ 37.80
N/A
52 Week Low
$37.73
$6.23
52 Week High
$52.23
$11.22

Technical Indicators

Market Signals
Indicator
GABC
BCRX
Relative Strength Index (RSI) 63.33 42.17
Support Level $48.22 $6.35
Resistance Level $51.97 $9.22
Average True Range (ATR) 0.89 0.30
MACD 0.26 0.00
Stochastic Oscillator 88.97 33.49

Price Performance

Historical Comparison
GABC
BCRX

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: